Global KRAS G12C Inhibitors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global KRAS G12C Inhibitors market size was valued at US$ 377 million in 2025 and is forecast to a readjusted size of US$ 5176 million by 2032 with a CAGR of 45.9% during review period.
KARC G12C inhibitors are targeted therapeutics for G12C mutation, a specific mutation in the KRAS gene. KRAS gene mutations are prevalent in a variety of cancers, particularly in non-small cell lung cancer (NSCLC), where G12C mutations are a common driver. Its mechanism of action is to form covalent bonds with cysteine residues of the KRAS G12C mutant protein, locking KRAS in its inactive conformation and blocking its signaling, thereby inhibiting the proliferation of tumor cells. The development of this class of drugs offers a new therapeutic avenue for cancer patients carrying the KRAS G12C mutation, especially for those who are not sensitive to conventional chemotherapy.
This report is a detailed and comprehensive analysis for global KRAS G12C Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global KRAS G12C Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global KRAS G12C Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global KRAS G12C Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global KRAS G12C Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
KRAS G12C Inhibitors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
KARC G12C inhibitors are targeted therapeutics for G12C mutation, a specific mutation in the KRAS gene. KRAS gene mutations are prevalent in a variety of cancers, particularly in non-small cell lung cancer (NSCLC), where G12C mutations are a common driver. Its mechanism of action is to form covalent bonds with cysteine residues of the KRAS G12C mutant protein, locking KRAS in its inactive conformation and blocking its signaling, thereby inhibiting the proliferation of tumor cells. The development of this class of drugs offers a new therapeutic avenue for cancer patients carrying the KRAS G12C mutation, especially for those who are not sensitive to conventional chemotherapy.
This report is a detailed and comprehensive analysis for global KRAS G12C Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global KRAS G12C Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global KRAS G12C Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global KRAS G12C Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global KRAS G12C Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for KRAS G12C Inhibitors
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
KRAS G12C Inhibitors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Garsorasib
- Fulzerasib
- Adagrasib
- Sotorasib
- Hospital
- Clinic
- Others
- Amgen
- Innovent Biologics, Inc.
- Mirati Therapeutics
- Genfleet Therapeutics (Shanghai), Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe KRAS G12C Inhibitors product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of KRAS G12C Inhibitors, with price, sales quantity, revenue, and global market share of KRAS G12C Inhibitors from 2021 to 2026.
- Chapter 3, the KRAS G12C Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the KRAS G12C Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and KRAS G12C Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of KRAS G12C Inhibitors.
- Chapter 14 and 15, to describe KRAS G12C Inhibitors sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global RABV-G Inhibitors Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 20 IU/mL
1.3.3 40 IU/mL
1.3.4 200 IU/mL
1.3.5 600 IU/mL
1.4 Market Analysis by Application
1.4.1 Overview: Global RABV-G Inhibitors Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global RABV-G Inhibitors Market Size & Forecast
1.5.1 Global RABV-G Inhibitors Consumption Value (2021 & 2025 & 2032)
1.5.2 Global RABV-G Inhibitors Sales Quantity (2021-2032)
1.5.3 Global RABV-G Inhibitors Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Synermore Biologics (Suzhou) Co., Ltd.
2.1.1 Synermore Biologics (Suzhou) Co., Ltd. Details
2.1.2 Synermore Biologics (Suzhou) Co., Ltd. Major Business
2.1.3 Synermore Biologics (Suzhou) Co., Ltd. RABV-G Inhibitors Product and Services
2.1.4 Synermore Biologics (Suzhou) Co., Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Synermore Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
2.2 NCPC New Drug Research & Development Co. Ltd.
2.2.1 NCPC New Drug Research & Development Co. Ltd. Details
2.2.2 NCPC New Drug Research & Development Co. Ltd. Major Business
2.2.3 NCPC New Drug Research & Development Co. Ltd. RABV-G Inhibitors Product and Services
2.2.4 NCPC New Drug Research & Development Co. Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 NCPC New Drug Research & Development Co. Ltd. Recent Developments/Updates
2.3 Zydus Cadila Healthcare Ltd.
2.3.1 Zydus Cadila Healthcare Ltd. Details
2.3.2 Zydus Cadila Healthcare Ltd. Major Business
2.3.3 Zydus Cadila Healthcare Ltd. RABV-G Inhibitors Product and Services
2.3.4 Zydus Cadila Healthcare Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Zydus Cadila Healthcare Ltd. Recent Developments/Updates
2.4 Serum Institute of India Pvt Ltd.
2.4.1 Serum Institute of India Pvt Ltd. Details
2.4.2 Serum Institute of India Pvt Ltd. Major Business
2.4.3 Serum Institute of India Pvt Ltd. RABV-G Inhibitors Product and Services
2.4.4 Serum Institute of India Pvt Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Serum Institute of India Pvt Ltd. Recent Developments/Updates
2.5 Chongqing Genrix Biopharmaceutical Co., Ltd.
2.5.1 Chongqing Genrix Biopharmaceutical Co., Ltd. Details
2.5.2 Chongqing Genrix Biopharmaceutical Co., Ltd. Major Business
2.5.3 Chongqing Genrix Biopharmaceutical Co., Ltd. RABV-G Inhibitors Product and Services
2.5.4 Chongqing Genrix Biopharmaceutical Co., Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Chongqing Genrix Biopharmaceutical Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABV-G INHIBITORS BY MANUFACTURER
3.1 Global RABV-G Inhibitors Sales Quantity by Manufacturer (2021-2026)
3.2 Global RABV-G Inhibitors Revenue by Manufacturer (2021-2026)
3.3 Global RABV-G Inhibitors Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of RABV-G Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 RABV-G Inhibitors Manufacturer Market Share in 2025
3.4.3 Top 6 RABV-G Inhibitors Manufacturer Market Share in 2025
3.5 RABV-G Inhibitors Market: Overall Company Footprint Analysis
3.5.1 RABV-G Inhibitors Market: Region Footprint
3.5.2 RABV-G Inhibitors Market: Company Product Type Footprint
3.5.3 RABV-G Inhibitors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global RABV-G Inhibitors Market Size by Region
4.1.1 Global RABV-G Inhibitors Sales Quantity by Region (2021-2032)
4.1.2 Global RABV-G Inhibitors Consumption Value by Region (2021-2032)
4.1.3 Global RABV-G Inhibitors Average Price by Region (2021-2032)
4.2 North America RABV-G Inhibitors Consumption Value (2021-2032)
4.3 Europe RABV-G Inhibitors Consumption Value (2021-2032)
4.4 Asia-Pacific RABV-G Inhibitors Consumption Value (2021-2032)
4.5 South America RABV-G Inhibitors Consumption Value (2021-2032)
4.6 Middle East & Africa RABV-G Inhibitors Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global RABV-G Inhibitors Sales Quantity by Type (2021-2032)
5.2 Global RABV-G Inhibitors Consumption Value by Type (2021-2032)
5.3 Global RABV-G Inhibitors Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global RABV-G Inhibitors Sales Quantity by Application (2021-2032)
6.2 Global RABV-G Inhibitors Consumption Value by Application (2021-2032)
6.3 Global RABV-G Inhibitors Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America RABV-G Inhibitors Sales Quantity by Type (2021-2032)
7.2 North America RABV-G Inhibitors Sales Quantity by Application (2021-2032)
7.3 North America RABV-G Inhibitors Market Size by Country
7.3.1 North America RABV-G Inhibitors Sales Quantity by Country (2021-2032)
7.3.2 North America RABV-G Inhibitors Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe RABV-G Inhibitors Sales Quantity by Type (2021-2032)
8.2 Europe RABV-G Inhibitors Sales Quantity by Application (2021-2032)
8.3 Europe RABV-G Inhibitors Market Size by Country
8.3.1 Europe RABV-G Inhibitors Sales Quantity by Country (2021-2032)
8.3.2 Europe RABV-G Inhibitors Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific RABV-G Inhibitors Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific RABV-G Inhibitors Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific RABV-G Inhibitors Market Size by Region
9.3.1 Asia-Pacific RABV-G Inhibitors Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific RABV-G Inhibitors Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America RABV-G Inhibitors Sales Quantity by Type (2021-2032)
10.2 South America RABV-G Inhibitors Sales Quantity by Application (2021-2032)
10.3 South America RABV-G Inhibitors Market Size by Country
10.3.1 South America RABV-G Inhibitors Sales Quantity by Country (2021-2032)
10.3.2 South America RABV-G Inhibitors Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa RABV-G Inhibitors Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa RABV-G Inhibitors Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa RABV-G Inhibitors Market Size by Country
11.3.1 Middle East & Africa RABV-G Inhibitors Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa RABV-G Inhibitors Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 RABV-G Inhibitors Market Drivers
12.2 RABV-G Inhibitors Market Restraints
12.3 RABV-G Inhibitors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of RABV-G Inhibitors and Key Manufacturers
13.2 Manufacturing Costs Percentage of RABV-G Inhibitors
13.3 RABV-G Inhibitors Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 RABV-G Inhibitors Typical Distributors
14.3 RABV-G Inhibitors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global RABV-G Inhibitors Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 20 IU/mL
1.3.3 40 IU/mL
1.3.4 200 IU/mL
1.3.5 600 IU/mL
1.4 Market Analysis by Application
1.4.1 Overview: Global RABV-G Inhibitors Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global RABV-G Inhibitors Market Size & Forecast
1.5.1 Global RABV-G Inhibitors Consumption Value (2021 & 2025 & 2032)
1.5.2 Global RABV-G Inhibitors Sales Quantity (2021-2032)
1.5.3 Global RABV-G Inhibitors Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Synermore Biologics (Suzhou) Co., Ltd.
2.1.1 Synermore Biologics (Suzhou) Co., Ltd. Details
2.1.2 Synermore Biologics (Suzhou) Co., Ltd. Major Business
2.1.3 Synermore Biologics (Suzhou) Co., Ltd. RABV-G Inhibitors Product and Services
2.1.4 Synermore Biologics (Suzhou) Co., Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Synermore Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
2.2 NCPC New Drug Research & Development Co. Ltd.
2.2.1 NCPC New Drug Research & Development Co. Ltd. Details
2.2.2 NCPC New Drug Research & Development Co. Ltd. Major Business
2.2.3 NCPC New Drug Research & Development Co. Ltd. RABV-G Inhibitors Product and Services
2.2.4 NCPC New Drug Research & Development Co. Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 NCPC New Drug Research & Development Co. Ltd. Recent Developments/Updates
2.3 Zydus Cadila Healthcare Ltd.
2.3.1 Zydus Cadila Healthcare Ltd. Details
2.3.2 Zydus Cadila Healthcare Ltd. Major Business
2.3.3 Zydus Cadila Healthcare Ltd. RABV-G Inhibitors Product and Services
2.3.4 Zydus Cadila Healthcare Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Zydus Cadila Healthcare Ltd. Recent Developments/Updates
2.4 Serum Institute of India Pvt Ltd.
2.4.1 Serum Institute of India Pvt Ltd. Details
2.4.2 Serum Institute of India Pvt Ltd. Major Business
2.4.3 Serum Institute of India Pvt Ltd. RABV-G Inhibitors Product and Services
2.4.4 Serum Institute of India Pvt Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Serum Institute of India Pvt Ltd. Recent Developments/Updates
2.5 Chongqing Genrix Biopharmaceutical Co., Ltd.
2.5.1 Chongqing Genrix Biopharmaceutical Co., Ltd. Details
2.5.2 Chongqing Genrix Biopharmaceutical Co., Ltd. Major Business
2.5.3 Chongqing Genrix Biopharmaceutical Co., Ltd. RABV-G Inhibitors Product and Services
2.5.4 Chongqing Genrix Biopharmaceutical Co., Ltd. RABV-G Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Chongqing Genrix Biopharmaceutical Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RABV-G INHIBITORS BY MANUFACTURER
3.1 Global RABV-G Inhibitors Sales Quantity by Manufacturer (2021-2026)
3.2 Global RABV-G Inhibitors Revenue by Manufacturer (2021-2026)
3.3 Global RABV-G Inhibitors Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of RABV-G Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 RABV-G Inhibitors Manufacturer Market Share in 2025
3.4.3 Top 6 RABV-G Inhibitors Manufacturer Market Share in 2025
3.5 RABV-G Inhibitors Market: Overall Company Footprint Analysis
3.5.1 RABV-G Inhibitors Market: Region Footprint
3.5.2 RABV-G Inhibitors Market: Company Product Type Footprint
3.5.3 RABV-G Inhibitors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global RABV-G Inhibitors Market Size by Region
4.1.1 Global RABV-G Inhibitors Sales Quantity by Region (2021-2032)
4.1.2 Global RABV-G Inhibitors Consumption Value by Region (2021-2032)
4.1.3 Global RABV-G Inhibitors Average Price by Region (2021-2032)
4.2 North America RABV-G Inhibitors Consumption Value (2021-2032)
4.3 Europe RABV-G Inhibitors Consumption Value (2021-2032)
4.4 Asia-Pacific RABV-G Inhibitors Consumption Value (2021-2032)
4.5 South America RABV-G Inhibitors Consumption Value (2021-2032)
4.6 Middle East & Africa RABV-G Inhibitors Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global RABV-G Inhibitors Sales Quantity by Type (2021-2032)
5.2 Global RABV-G Inhibitors Consumption Value by Type (2021-2032)
5.3 Global RABV-G Inhibitors Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global RABV-G Inhibitors Sales Quantity by Application (2021-2032)
6.2 Global RABV-G Inhibitors Consumption Value by Application (2021-2032)
6.3 Global RABV-G Inhibitors Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America RABV-G Inhibitors Sales Quantity by Type (2021-2032)
7.2 North America RABV-G Inhibitors Sales Quantity by Application (2021-2032)
7.3 North America RABV-G Inhibitors Market Size by Country
7.3.1 North America RABV-G Inhibitors Sales Quantity by Country (2021-2032)
7.3.2 North America RABV-G Inhibitors Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe RABV-G Inhibitors Sales Quantity by Type (2021-2032)
8.2 Europe RABV-G Inhibitors Sales Quantity by Application (2021-2032)
8.3 Europe RABV-G Inhibitors Market Size by Country
8.3.1 Europe RABV-G Inhibitors Sales Quantity by Country (2021-2032)
8.3.2 Europe RABV-G Inhibitors Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific RABV-G Inhibitors Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific RABV-G Inhibitors Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific RABV-G Inhibitors Market Size by Region
9.3.1 Asia-Pacific RABV-G Inhibitors Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific RABV-G Inhibitors Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America RABV-G Inhibitors Sales Quantity by Type (2021-2032)
10.2 South America RABV-G Inhibitors Sales Quantity by Application (2021-2032)
10.3 South America RABV-G Inhibitors Market Size by Country
10.3.1 South America RABV-G Inhibitors Sales Quantity by Country (2021-2032)
10.3.2 South America RABV-G Inhibitors Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa RABV-G Inhibitors Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa RABV-G Inhibitors Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa RABV-G Inhibitors Market Size by Country
11.3.1 Middle East & Africa RABV-G Inhibitors Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa RABV-G Inhibitors Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 RABV-G Inhibitors Market Drivers
12.2 RABV-G Inhibitors Market Restraints
12.3 RABV-G Inhibitors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of RABV-G Inhibitors and Key Manufacturers
13.2 Manufacturing Costs Percentage of RABV-G Inhibitors
13.3 RABV-G Inhibitors Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 RABV-G Inhibitors Typical Distributors
14.3 RABV-G Inhibitors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global KRAS G12C Inhibitors Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global KRAS G12C Inhibitors Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen KRAS G12C Inhibitors Product and Services
Table 6. Amgen KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Amgen Recent Developments/Updates
Table 8. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Innovent Biologics, Inc. Major Business
Table 10. Innovent Biologics, Inc. KRAS G12C Inhibitors Product and Services
Table 11. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Innovent Biologics, Inc. Recent Developments/Updates
Table 13. Mirati Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Mirati Therapeutics Major Business
Table 15. Mirati Therapeutics KRAS G12C Inhibitors Product and Services
Table 16. Mirati Therapeutics KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Mirati Therapeutics Recent Developments/Updates
Table 18. Genfleet Therapeutics (Shanghai), Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Genfleet Therapeutics (Shanghai), Inc. Major Business
Table 20. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product and Services
Table 21. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Genfleet Therapeutics (Shanghai), Inc. Recent Developments/Updates
Table 23. Global KRAS G12C Inhibitors Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 24. Global KRAS G12C Inhibitors Revenue by Manufacturer (2021-2026) & (USD Million)
Table 25. Global KRAS G12C Inhibitors Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 26. Market Position of Manufacturers in KRAS G12C Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 27. Head Office and KRAS G12C Inhibitors Production Site of Key Manufacturer
Table 28. KRAS G12C Inhibitors Market: Company Product Type Footprint
Table 29. KRAS G12C Inhibitors Market: Company Product Application Footprint
Table 30. KRAS G12C Inhibitors New Market Entrants and Barriers to Market Entry
Table 31. KRAS G12C Inhibitors Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global KRAS G12C Inhibitors Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 33. Global KRAS G12C Inhibitors Sales Quantity by Region (2021-2026) & (K Units)
Table 34. Global KRAS G12C Inhibitors Sales Quantity by Region (2027-2032) & (K Units)
Table 35. Global KRAS G12C Inhibitors Consumption Value by Region (2021-2026) & (USD Million)
Table 36. Global KRAS G12C Inhibitors Consumption Value by Region (2027-2032) & (USD Million)
Table 37. Global KRAS G12C Inhibitors Average Price by Region (2021-2026) & (US$/Unit)
Table 38. Global KRAS G12C Inhibitors Average Price by Region (2027-2032) & (US$/Unit)
Table 39. Global KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 40. Global KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 41. Global KRAS G12C Inhibitors Consumption Value by Type (2021-2026) & (USD Million)
Table 42. Global KRAS G12C Inhibitors Consumption Value by Type (2027-2032) & (USD Million)
Table 43. Global KRAS G12C Inhibitors Average Price by Type (2021-2026) & (US$/Unit)
Table 44. Global KRAS G12C Inhibitors Average Price by Type (2027-2032) & (US$/Unit)
Table 45. Global KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 46. Global KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 47. Global KRAS G12C Inhibitors Consumption Value by Application (2021-2026) & (USD Million)
Table 48. Global KRAS G12C Inhibitors Consumption Value by Application (2027-2032) & (USD Million)
Table 49. Global KRAS G12C Inhibitors Average Price by Application (2021-2026) & (US$/Unit)
Table 50. Global KRAS G12C Inhibitors Average Price by Application (2027-2032) & (US$/Unit)
Table 51. North America KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 52. North America KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 53. North America KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 54. North America KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 55. North America KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 56. North America KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 57. North America KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 58. North America KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Europe KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 60. Europe KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 61. Europe KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 62. Europe KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 63. Europe KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 64. Europe KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 65. Europe KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 66. Europe KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 67. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 68. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 69. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 71. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Region (2027-2032) & (K Units)
Table 73. Asia-Pacific KRAS G12C Inhibitors Consumption Value by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific KRAS G12C Inhibitors Consumption Value by Region (2027-2032) & (USD Million)
Table 75. South America KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 76. South America KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 77. South America KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 78. South America KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 79. South America KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 80. South America KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 81. South America KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 82. South America KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 84. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 85. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 87. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 89. Middle East & Africa KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 91. KRAS G12C Inhibitors Raw Material
Table 92. Key Manufacturers of KRAS G12C Inhibitors Raw Materials
Table 93. KRAS G12C Inhibitors Typical Distributors
Table 94. KRAS G12C Inhibitors Typical Customers
Table 1. Global KRAS G12C Inhibitors Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global KRAS G12C Inhibitors Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen KRAS G12C Inhibitors Product and Services
Table 6. Amgen KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Amgen Recent Developments/Updates
Table 8. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Innovent Biologics, Inc. Major Business
Table 10. Innovent Biologics, Inc. KRAS G12C Inhibitors Product and Services
Table 11. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Innovent Biologics, Inc. Recent Developments/Updates
Table 13. Mirati Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Mirati Therapeutics Major Business
Table 15. Mirati Therapeutics KRAS G12C Inhibitors Product and Services
Table 16. Mirati Therapeutics KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Mirati Therapeutics Recent Developments/Updates
Table 18. Genfleet Therapeutics (Shanghai), Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Genfleet Therapeutics (Shanghai), Inc. Major Business
Table 20. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product and Services
Table 21. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Genfleet Therapeutics (Shanghai), Inc. Recent Developments/Updates
Table 23. Global KRAS G12C Inhibitors Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 24. Global KRAS G12C Inhibitors Revenue by Manufacturer (2021-2026) & (USD Million)
Table 25. Global KRAS G12C Inhibitors Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 26. Market Position of Manufacturers in KRAS G12C Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 27. Head Office and KRAS G12C Inhibitors Production Site of Key Manufacturer
Table 28. KRAS G12C Inhibitors Market: Company Product Type Footprint
Table 29. KRAS G12C Inhibitors Market: Company Product Application Footprint
Table 30. KRAS G12C Inhibitors New Market Entrants and Barriers to Market Entry
Table 31. KRAS G12C Inhibitors Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global KRAS G12C Inhibitors Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 33. Global KRAS G12C Inhibitors Sales Quantity by Region (2021-2026) & (K Units)
Table 34. Global KRAS G12C Inhibitors Sales Quantity by Region (2027-2032) & (K Units)
Table 35. Global KRAS G12C Inhibitors Consumption Value by Region (2021-2026) & (USD Million)
Table 36. Global KRAS G12C Inhibitors Consumption Value by Region (2027-2032) & (USD Million)
Table 37. Global KRAS G12C Inhibitors Average Price by Region (2021-2026) & (US$/Unit)
Table 38. Global KRAS G12C Inhibitors Average Price by Region (2027-2032) & (US$/Unit)
Table 39. Global KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 40. Global KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 41. Global KRAS G12C Inhibitors Consumption Value by Type (2021-2026) & (USD Million)
Table 42. Global KRAS G12C Inhibitors Consumption Value by Type (2027-2032) & (USD Million)
Table 43. Global KRAS G12C Inhibitors Average Price by Type (2021-2026) & (US$/Unit)
Table 44. Global KRAS G12C Inhibitors Average Price by Type (2027-2032) & (US$/Unit)
Table 45. Global KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 46. Global KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 47. Global KRAS G12C Inhibitors Consumption Value by Application (2021-2026) & (USD Million)
Table 48. Global KRAS G12C Inhibitors Consumption Value by Application (2027-2032) & (USD Million)
Table 49. Global KRAS G12C Inhibitors Average Price by Application (2021-2026) & (US$/Unit)
Table 50. Global KRAS G12C Inhibitors Average Price by Application (2027-2032) & (US$/Unit)
Table 51. North America KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 52. North America KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 53. North America KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 54. North America KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 55. North America KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 56. North America KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 57. North America KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 58. North America KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Europe KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 60. Europe KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 61. Europe KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 62. Europe KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 63. Europe KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 64. Europe KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 65. Europe KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 66. Europe KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 67. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 68. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 69. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 71. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific KRAS G12C Inhibitors Sales Quantity by Region (2027-2032) & (K Units)
Table 73. Asia-Pacific KRAS G12C Inhibitors Consumption Value by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific KRAS G12C Inhibitors Consumption Value by Region (2027-2032) & (USD Million)
Table 75. South America KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 76. South America KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 77. South America KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 78. South America KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 79. South America KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 80. South America KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 81. South America KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 82. South America KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Type (2021-2026) & (K Units)
Table 84. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Type (2027-2032) & (K Units)
Table 85. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Application (2027-2032) & (K Units)
Table 87. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa KRAS G12C Inhibitors Sales Quantity by Country (2027-2032) & (K Units)
Table 89. Middle East & Africa KRAS G12C Inhibitors Consumption Value by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa KRAS G12C Inhibitors Consumption Value by Country (2027-2032) & (USD Million)
Table 91. KRAS G12C Inhibitors Raw Material
Table 92. Key Manufacturers of KRAS G12C Inhibitors Raw Materials
Table 93. KRAS G12C Inhibitors Typical Distributors
Table 94. KRAS G12C Inhibitors Typical Customers
LIST OF FIGURES
Figure 1. KRAS G12C Inhibitors Picture
Figure 2. Global KRAS G12C Inhibitors Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global KRAS G12C Inhibitors Revenue Market Share by Type in 2025
Figure 4. Garsorasib Examples
Figure 5. Fulzerasib Examples
Figure 6. Adagrasib Examples
Figure 7. Sotorasib Examples
Figure 8. Global KRAS G12C Inhibitors Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Global KRAS G12C Inhibitors Revenue Market Share by Application in 2025
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global KRAS G12C Inhibitors Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global KRAS G12C Inhibitors Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global KRAS G12C Inhibitors Sales Quantity (2021-2032) & (K Units)
Figure 16. Global KRAS G12C Inhibitors Price (2021-2032) & (US$/Unit)
Figure 17. Global KRAS G12C Inhibitors Sales Quantity Market Share by Manufacturer in 2025
Figure 18. Global KRAS G12C Inhibitors Revenue Market Share by Manufacturer in 2025
Figure 19. Producer Shipments of KRAS G12C Inhibitors by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 20. Top 3 KRAS G12C Inhibitors Manufacturer (Revenue) Market Share in 2025
Figure 21. Top 6 KRAS G12C Inhibitors Manufacturer (Revenue) Market Share in 2025
Figure 22. Global KRAS G12C Inhibitors Sales Quantity Market Share by Region (2021-2032)
Figure 23. Global KRAS G12C Inhibitors Consumption Value Market Share by Region (2021-2032)
Figure 24. North America KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 27. South America KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 29. Global KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 30. Global KRAS G12C Inhibitors Consumption Value Market Share by Type (2021-2032)
Figure 31. Global KRAS G12C Inhibitors Average Price by Type (2021-2032) & (US$/Unit)
Figure 32. Global KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 33. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2032)
Figure 34. Global KRAS G12C Inhibitors Average Price by Application (2021-2032) & (US$/Unit)
Figure 35. North America KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 36. North America KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 37. North America KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 38. North America KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 39. United States KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 43. Europe KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 44. Europe KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 45. Europe KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 47. France KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 52. Asia-Pacific KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 53. Asia-Pacific KRAS G12C Inhibitors Sales Quantity Market Share by Region (2021-2032)
Figure 54. Asia-Pacific KRAS G12C Inhibitors Consumption Value Market Share by Region (2021-2032)
Figure 55. China KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 58. India KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 61. South America KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 62. South America KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 63. South America KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 64. South America KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 68. Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 69. Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 70. Middle East & Africa KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 72. Egypt KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 74. South Africa KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 75. KRAS G12C Inhibitors Market Drivers
Figure 76. KRAS G12C Inhibitors Market Restraints
Figure 77. KRAS G12C Inhibitors Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of KRAS G12C Inhibitors in 2025
Figure 80. Manufacturing Process Analysis of KRAS G12C Inhibitors
Figure 81. KRAS G12C Inhibitors Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. KRAS G12C Inhibitors Picture
Figure 2. Global KRAS G12C Inhibitors Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global KRAS G12C Inhibitors Revenue Market Share by Type in 2025
Figure 4. Garsorasib Examples
Figure 5. Fulzerasib Examples
Figure 6. Adagrasib Examples
Figure 7. Sotorasib Examples
Figure 8. Global KRAS G12C Inhibitors Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Global KRAS G12C Inhibitors Revenue Market Share by Application in 2025
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global KRAS G12C Inhibitors Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global KRAS G12C Inhibitors Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global KRAS G12C Inhibitors Sales Quantity (2021-2032) & (K Units)
Figure 16. Global KRAS G12C Inhibitors Price (2021-2032) & (US$/Unit)
Figure 17. Global KRAS G12C Inhibitors Sales Quantity Market Share by Manufacturer in 2025
Figure 18. Global KRAS G12C Inhibitors Revenue Market Share by Manufacturer in 2025
Figure 19. Producer Shipments of KRAS G12C Inhibitors by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 20. Top 3 KRAS G12C Inhibitors Manufacturer (Revenue) Market Share in 2025
Figure 21. Top 6 KRAS G12C Inhibitors Manufacturer (Revenue) Market Share in 2025
Figure 22. Global KRAS G12C Inhibitors Sales Quantity Market Share by Region (2021-2032)
Figure 23. Global KRAS G12C Inhibitors Consumption Value Market Share by Region (2021-2032)
Figure 24. North America KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 27. South America KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 29. Global KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 30. Global KRAS G12C Inhibitors Consumption Value Market Share by Type (2021-2032)
Figure 31. Global KRAS G12C Inhibitors Average Price by Type (2021-2032) & (US$/Unit)
Figure 32. Global KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 33. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2032)
Figure 34. Global KRAS G12C Inhibitors Average Price by Application (2021-2032) & (US$/Unit)
Figure 35. North America KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 36. North America KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 37. North America KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 38. North America KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 39. United States KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 40. Canada KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 41. Mexico KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 42. Europe KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 43. Europe KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 44. Europe KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 45. Europe KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 47. France KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 52. Asia-Pacific KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 53. Asia-Pacific KRAS G12C Inhibitors Sales Quantity Market Share by Region (2021-2032)
Figure 54. Asia-Pacific KRAS G12C Inhibitors Consumption Value Market Share by Region (2021-2032)
Figure 55. China KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 58. India KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 61. South America KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 62. South America KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 63. South America KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 64. South America KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share by Type (2021-2032)
Figure 68. Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share by Application (2021-2032)
Figure 69. Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share by Country (2021-2032)
Figure 70. Middle East & Africa KRAS G12C Inhibitors Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 72. Egypt KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 74. South Africa KRAS G12C Inhibitors Consumption Value (2021-2032) & (USD Million)
Figure 75. KRAS G12C Inhibitors Market Drivers
Figure 76. KRAS G12C Inhibitors Market Restraints
Figure 77. KRAS G12C Inhibitors Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of KRAS G12C Inhibitors in 2025
Figure 80. Manufacturing Process Analysis of KRAS G12C Inhibitors
Figure 81. KRAS G12C Inhibitors Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
